Form 8-K - Current report:
SEC Accession No. 0000950170-25-018820
Filing Date
2025-02-12
Accepted
2025-02-12 16:05:08
Documents
13
Period of Report
2025-02-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K meip-20250212.htm   iXBRL 8-K 45114
2 EX-99.1 meip-ex99_1.htm EX-99.1 179082
3 GRAPHIC img183464774_0.jpg GRAPHIC 166701
  Complete submission text file 0000950170-25-018820.txt   575783

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20250212.xsd EX-101.SCH 24867
15 EXTRACTED XBRL INSTANCE DOCUMENT meip-20250212_htm.xml XML 4705
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 25614754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)